New generation of microplate readers

Published: 1-Apr-2011
Manufacturing

Biochrom has a new generation of microplate readers, tailored to meet the needs of modern labs

Instrument manufacturer, Biochrom, Cambridge, UK, has launched the new EZ Read 400 microplate reader through its international network of distributors.

Lab workers can now benefit from the cost-effective and easy to use instrument. Offering flexibility and full performance with no redundant features, the filter-based, PC-controlled EZ Read 400 can be tailored to suit application requirements.


The ability to perform single or dual wavelength measurements to incorporate reference wavelength readings, and the option to do so at timed-intervals, means the EZ Read 400 is ideal for ELISA, protein, cell biology and kinetic assays.

Designed to take up the minimum of bench space, and incorporating ADAP Basic PC software and USB connections for easy instrument connection and data transfer, the new EZ Read 400 can be configured with a choice of filter options within a wavelength range of 400-750 nm
, a choice of data analysis software packages
 and a QC plate for instrument validation.



See more

You may also like

Manufacturing

Of interest in 2010: the Anthos 2010 microplate reader

Read more
Order before 30 June for free software upgrade

Trending Articles

  1. BASF announces up to 20% price increase on pharmaceutical excipients and selected APIs BASF Pharma Solutions has implemented an immediate global price adjustment of up to 20% across its pharmaceutical excipients and selected active pharmaceutical ingredients portfolio, citing rising energy and raw material costs
  2. Romaco Holding appoint Chief Sales Officer Nicola Magriotis will be responsible for the sales and service organisation of the international Romaco Group
  3. ImmuneOncia Therapeutics and Lonza collaborate to manufacture Danburstotug Lonza to support development and manufacturing of ImmuneOncia’s Danburstotug with a complete and integrated end-to-end drug substance and drug product solution
  4. ROIS CDMO closes on the acquisition of US Injectable Manufacturing Facility This strategic move establishes ROIS as a global Contract Development and Manufacturing Organisation (CDMO), expanding from its existing European operations to now offer US-based sterile production
  5. Prange Pharma acquires MSD Animal Health's Italian site to launch Aprilia Animal Health as European veterinary CDMO German pharma company Prange Pharma has completed the acquisition of MSD Animal Health's manufacturing facility in Aprilia, Italy, relaunching it as Aprilia Animal Health to serve as a dedicated European contract manufacturing platform for the veterinary pharmaceuticals sector

Upcoming event

Making Pharmaceuticals

21–22 April 2026 | Exhibition | Coventry, UK See all

You may also like

Manufacturing

Of interest in 2010: the Anthos 2010 microplate reader

Order before 30 June for free software upgrade
Manufacturing

UK pharmaceutical manufacturers struggling to meet F-Gas compliance amid ageing cooling infrastructure

A new Aggreko report reveals that nearly all UK pharmaceutical manufacturers are facing barriers to upgrading cooling systems ahead of the accelerating F-Gas phase-down timeline
Manufacturing

Labtex - Fresh thinking and innovative solutions

Labtex states: "We are proud to provide unique solutions for laboratories and pilot plants across the UK"
Manufacturing

Nemera partners with Therakind to expand nasal drug delivery portfolio with DriDose dry powder platform

The manufacturer has announced a strategic partnership with UK pharmaceutical company Therakind to advance the DriDose intranasal dry powder platform, adding dry powder delivery capabilities to complement Nemera's existing liquid nasal formulation offering
Manufacturing

L.B. Bohle hosts successful continuous manufacturing workshop in Brazil

Focus on continuous wet granulation and drying for research, development and small-scale production
Manufacturing

Swiss Rockets collaborates with Lonza to advance Torqur’s oncology drug candidate bimiralisib into late-stage clinical development

Lonza to provide cGMP manufacturing and technical support to advance bimiralisib into late-stage clinical development
Manufacturing

Symbiosis completes full ICH climatic zone coverage with new stability chamber addition

Sterile injectable CDMO Symbiosis Pharmaceutical Services has installed a 30°C stability chamber at its Stirling facility, completing its coverage of all four ICH-defined climatic zones and strengthening its commercial drug product supply capabilities for global markets
Subscribe now